Eckert & Ziegler SE is a Germany-based Company, which is a provider of isotope technology for medical, scientific and industrial use with focus on cancer therapy, industrial radiometry and nuclear-medical imaging. The Company operates through three segments: Radiation Therapy, Isotope Products and Radiopharma. The Radiation Therapy segment operates through Eckert & Ziegler BEBIG and produces and distributes medical products for the treatment of cancer using brachytherapy. The Isotope Products segment provides sealed and unsealed radiation sources for medical imaging, industrial gauging, measurement and analysis, reference, calibration and environmental monitoring sources and solutions, as well as bulk radioisotopes for pharmaceutical, therapeutic and industrial product manufacturers. The Radiopharma segment specializes in molecular imaging and nuclear medicine, and supplies various radiopharmaceuticals, radiochemicals and related equipment.
Company Information
About this company
Key people
Andreas Eckert
Chairman of the Supervisory Board
Harald Hasselmann
Chairman of the Executive Board
Helmut Grothe
Deputy Chairman of the Supervisory Board
Joseph Hathcock
Member of the Group Executive Committee, Isotope Products Segment
Gunnar Mann
Member of the Group Executive Committee, Medical Segment (Operations)
Ana Ramirez
Member of the Group Executive Committee, Isotope Products Segment
Franklin B. Yeager
Member of the Executive Board, Isotope Products Segment
Edgar Loeffler
Independent Member of the Supervisory Board
Albert Rupprecht
Independent Member of the Supervisory Board
Paola Eckert-palvarini
Member of the Supervisory Board
Jutta Ludwig
Member of the Supervisory Board
Click to see more
Key facts
- Shares in issue63.52m
- EPICEUZ
- ISINDE0005659700
- LocationGermany
- SectorBasic Materials
- IndustryChemical Manufacturing
- Market cap€998.47m
- Employees1,112
- ExchangeXETRA
- Index
- Website
Data policy - All information should be used for indicative purposes only. You should independently check data before making any investment decision. HL cannot guarantee that the data is accurate or complete, and accepts no responsibility for how it may be used. Overview data is sourced from Refinitiv.